SAMANTHA WENZEL: Open Payments
NPI 1942727979 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,788 in 83 payments from 21 companies in 2025. Trend: 2023 $1,363 · 2024 $2,200 · 2025 $1,788
Food & beverage: $1,699Education: $89
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 9 | $323 |
| Novartis Pharmaceuticals Corporation | 8 | $173 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| BridgeBio Pharma, Inc. | 7 | $133 |
| Merck Sharp & Dohme LLC | 7 | $130 |
| E.R. Squibb & Sons, L.L.C. | 5 | $115 |
| Alnylam Pharmaceuticals Inc. | 5 | $107 |
| PFIZER INC. | 4 | $94 |
| CVRx, Inc. | 7 | $91 |
| ABIOMED | 4 | $71 |
Products named: LEQVIO, OPSUMIT, Attruby, ONPATTRO, UPTRAVI, VYNDAQEL, VERQUVO, CAMZYOS.
Industry payments across FL — which companies pay providers there.
